170476 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans Assays involving receptors, cell surface antigens or cell surface determinants
Sub-classes:Mesothelin-Binding Theranostic Fibronectin Type III Tenth Domain (Fn3) Compounds
#2METHODS FOR MEASURING LYMPHOCYTE ACTIVITY
#3DETECTING CANCER
#4SYSTEMS AND METHODS FOR OPTOGENETIC ACTIVATION AND MONITORING
#5METHODS OF DETECTING IMMUNE CELLS
#6PEPTIDES THAT SELECTIVELY BIND TO Trop2 AND USE THEREOF
#7DEFECTIVE CALCIUM SIGNALING AS A TOOL IN AUTISM SPECTRUM DISORDERS
#8METHODS FOR TREATING AND DIAGNOSING SYSTEMIC LUPUS ERYTHEMATOSUS
#9DYNAMIC CLAMPS AND METHODS OF USE THEREOF
#10METHOD FOR IDENTIFYING CANCER PATIENTS THAT BENEFIT FROM ANTI-CLEVER-1 TREATMENT
#11CELL-FREE CLOSTRIDIAL NEUROTOXIN ASSAYS
#12ANTIBODIES FOR DETECTION AND ENRICHMENT OF FETAL CELLS AND THEIR USE
#13SPATIAL MRNA/PROTEIN CO-ASSAYS USING APTAMERS
#14METHOD FOR IDENTIFYING CANCER PATIENTS THAT BENEFIT FROM ANTI-CLEVER-1 TREATMENT
#15COMBINATION THERAPY OF CLAUDIN 18.2 ANTAGONIST AND PD-1/PD-L1 AXIS INHIBITOR
#16METHODS FOR TREATING ACUTE KIDNEY INJURY
#17MUTANT AND MISLOCALIZED CELL SURFACE NUCLEOPHOSMIN 1 AS A DIAGNOSTIC AND THERAPEUTIC TARGET OF HUMAN DISEASE
#18METHODS FOR ISOLATING NEURAL STEM AND PROGENITOR CELLS FROM THE DEVELOPING HUMAN BRAIN
#19QUANTIFICATION OF LIGAND BIAS AND MUTATION-INDUCED SIGNALING BIAS IN EGFR PHOSPHORYLATION IN DIRECT RESPONSE TO LIGAND BINDING
#20EXPRESSION SYSTEMS FOR THE ALPHA6BETA4 NICOTINIC ACETYLCHOLINE RECEPTOR AND METHODS OF USE THEREOF
#21ANTIBODIES AGAINST CLAUDIN-6 AND USES THEREOF
#22CLDN18.2 ANTIBODY AND USE THEREOF
#23NANOVESICLE COMPRISING HETERODIMERIC G-PROTEIN COUPLED RECEPTOR, METHOD FOR PREPARING NANOVESICLE, FIELD EFFECT TRANSISTOR-BASED TASTE SENSOR COMPRISING NANOVESICLE, AND METHOD FOR MANUFACTURING TASTE SENSOR
#24Methods and Compositions for Treating or Preventing Neurological Injury or Neurological Disorders
#25Blood Biomarkers and Diagnostic Methods for Small Vessel Diseases
#26A BIOMARKER FOR DETERMINING ALZHEIMER'S DISEASE
#27OLFACTORY RECEPTOR GENE FOR DIAGNOSING SKIN AGING AND USE THEREOF
#28SENESCENT CELL SURFACE MARKERS
#29Diagnosis of Congenital Heart Block
#30METHOD FOR PREDICTING PROGNOSTIC INDICATIONS OF PANCREATIC CANCER PATIENTS
#31MULTI-OMIC DETERMINATION OF FERTILITY FITNESS
#32MARKER FOR DIAGNOSING MULTIPLE SCLEROSIS AND USE THEREOF
#33ANALYTE QUANTITATION
#34CELLS EXPRESSING UMAMI TASTE RECEPTORS AND USES THEREOF
#35RENAL CELL POPULATIONS AND USES THEREOF
#36SERS NANO-PARTICLE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF TO METHOD FOR DISTINGUISHING CTCS FROM WBCS
#37ANTIBODIES TARGETING THE B-CELL RECEPTOR OF CHRONIC LYMPHOCYTIC LEUKEMIA AND USES THEREOF
#38PHARMACEUTICAL COMPOSITION FOR TREATING CANCER
#39COMPANION METHODS AND KITS FOR IL-2-BASED THERAPIES AND MESENCHYMAL STEM CELL-BASED THERAPIES
#40ANTI-Ly6E ANTIBODIES, IMMUNOCONJUGATES, AND USES THEREOF
#41BISTABLE POLYNUCLEOTIDE DEVICES FOR THE SENSING AND QUANTIFICATION OF MOLECULAR EVENTS
#42MATERIALS AND METHODS FOR EVALUATING AND TREATING NEUROMYELITIS OPTICA (NMO)
#43COMPOUND THAT SPECIFICALLY BINDS TO KIR3DL2 FOR USE IN THE TREATMENT OF PERIPHERAL T CELL LYMPHOMA
#44BIOMARKERS FOR THE TREATMENT OF INTERSTITIAL LUNG DISEASE
#45CARDIAC CALCIUM HANDLING MACHINERY REMODELED IN FRIEDREICH'S ATAXIA
#46IN VITRO METHODS FOR DETECTING DLL1
#47CDH17 ANTIBODIES AND METHODS OF TREATING CANCER
#48PROTEIN BIOMARKER INDICATORS OF NEUROLOGICAL INJURY AND/OR DISEASE AND METHODS OF USE THEREOF
#49Methods for Categorizing and Treating Subjects at Risk for Pulmonary Exacerbation and Disease Progression
#50METHODS FOR ISOLATING SURFACE MARKER DISPLAYING AGENTS
#5120-HETE RECEPTOR (GPR75) ANTAGONISTS AND METHODS OF USE
#52SYSTEMS AND METHODS FOR THE ANALYSIS OF BIOLOGICAL SAMPLES
#53METHOD FOR THE MANAGEMENT OF ANTIBIOTIC ADMINISTRATION
#54RATIOS OF sFlt-1 TO P1GF OR ENDOGLIN TO P1GF AS BIOMARKERS FOR PREECLAMPSIA RELATED ADVERSE OUTCOMES AFTER BIRTH
#55SORTING WITH COUNTER SELECTION USING SEQUENCE SIMILAR PEPTIDES
#56Tissue-Specific Extracellular Vesicle Isolation and Validation
#57CLAUDIN 18.2-BINDING ANTIBODIES AND FRAGMENTS THEREOF
#58METHODS OF TREATING CANCER BY TARGETING TUMOR-ASSOCIATED MACROPHAGES
#59COMPOSITIONS, SYSTEMS, AND METHODS FOR DETERMINATION OF T2R AND/OR T1R PHENOTYPE IN INDIVIDUALS TO PREDICT CANNABIS TASTING PREFERENCES, CHARACTERIZATION OF CANNABIS IN RELATION TO INDIVIDUAL TASTING PREFERENCES, AND SELECTION OF CANNABIS
#60CORNEAL ENDOTHELIAL CELL MARKER
#61ANTIBODY BINDING TO LINKER OF scFv OR LIKE
#62TIBTECH COMPOSITIONS AND METHODS FOR DETECTING CDH17
#63METHOD FOR SCREENING SUBSTANCE THAT SUPPRESSES 4-METHYLACETOPHENONE ODOR, AND METHOD FOR SUPPRESSING 4-METHYL ACETOPHENONE ODOR
#64METHOD FOR LABELING CELLS
#65ANTI-TROP2 SINGLE-DOMAIN ANTIBODY AND USE THEREOF
#66BIOMARKERS TO DETECT RISK OF SINUSOIDAL OBSTRUCTION SYNDROME
#67METHOD OF SCREENING COMPOUNDS FOR TREATING CNS DISORDERS
#68COMBINATORIAL USE OF MARKERS TO ISOLATE SYNAPTIC GLIA TO GENERATE SYNAPSES IN A DISH FOR HIGH-THROUGHPUT AND HIGH-CONTENT DRUG DISCOVERY AND TESTING
#69DRUG FOR PREVENTING, ALLEVIATING OR TREATING MUCOSAL ADHESION AND USE THEREOF
#70MULTIPLEXED NANO-BIOSENSOR SYSTEM FOR EARLY DETECTION OF DIABETES
#71COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING OR AMELIORATING NONALCOHOLIC FATTY LIVER DISEASE AND RELATED DISEASES OR DISORDERS
#72PANCREATIC CANCER DIAGNOSIS ASSISTANCE METHOD AND PHARMACEUTICAL COMPOUND FOR TREATING PANCREATIC CANCER
#73DKK1/HLA-A2 BINDING MOLECULES AND METHODS OF THEIR USE
#74METHODS FOR CLASSIFYING TUMORS AND USES THEREFOR
#75Systems and Methods for Assessment of Lipid Membrane-Associated Molecule Kinetics, Dynamics, and Interactions
#76METHOD FOR EVALUATING RISK OF ACUTE CEREBRAL VASCULAR DISEASE USING SOLUBLE CLEC2
#77MEANS AND METHODS FOR THE DIAGNOSIS, CLASSIFICATION AND/OR MONITORING OF PEDIATRIC TUMORS
#78PATCHED-1 MONOCLONAL ANTIBODIES AND METHODS OF USE
#79TREATMENT OF CANCER IN PATIENTS WITH SOLUBLE FR-ALPHA
#80METHODS FOR TREATING CANCER USING ANTI-CTLA4 ANTIBODIES
#81A 3-LASER 13-COLOR B CELL MONITORING PANEL AND REAGENT KIT FOR ANALYZING B CELL SUBSETS IN ANTI-CD20 TREATED AUTOIMMUNE PATIENTS
#82METHOD FOR THE DETECTION OF ORGAN DERIVED EXTRACELLULAR VESICLES
#83MOLECULES THAT BIND TO AND STABILIZE TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2 (TREM2)
#84DEFECTIVE CALCIUM SIGNALING AS A TOOL IN AUTISM SPECTRUM DISORDERS
#85NOVEL TRIAZINE-BASED AMPHIPHILIC COMPOUND AND USE THEREOF
#86METHOD FOR DETECTING OR QUANTIFYING PHOTOAGED CELLS, APPLICATION OF SAME, AND METHOD FOR PREPARING PHOTOAGED CELLS
#87TEST FOR MILD COGNITIVE IMPAIRMENT
#88Epitope of Regulatory T Cell Surface Antigen, and Antibody Specifically Binding Thereto
#89LIPOPEPTIDES FOR USE IN TREATING LIVER DISEASES AND CARDIOVASCULAR DISEASES
#90BIOMARKERS ON CELLULAR ENDOCRINE MODELS FOR ENDOCRINE DISRUPTION ASSESSMENT
#91ANTIBODIES THAT BIND TO AXL PROTEINS
#92METHOD FOR MULTIMODAL PROFILING OF INDIVIDUAL EXTRACELLULAR VESICLES
#93METHOD FOR INHIBITING TUMOUR CELL GROWTH BASED ON CCDC112
#94MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
#95ENGINEERED MULTICELLULAR ORGANISMS
#96ANTIBODIES THAT BIND TO AXL PROTEINS
#97ANTIBODIES TARGETING G-PROTEIN COUPLED RECEPTOR AND METHODS OF USE
#98MATERIALS AND METHODS FOR EVALUATING AND TREATING NEUROMYELITIS OPTICA (NMO)
#99METHOD FOR ASSESSING THE OPSONOPHAGOCYTOTIC CAPACITY OR TROGOCYTOTIC CAPACITY OF AN ANTIGEN-BINDING MOLECULE
#10020-HETE RECEPTOR (GPR75) ANTAGONISTS AND METHODS OF USE
#101METHODS FOR THE DIAGNOSIS AND TREATMENT OF ENDOMETRIOSIS
#102Compositions And Methods Comprising D-Cysteine Or A D-Derivative Thereof
#103A METHOD OF EVALUATING SPERM HEALTH AND IDENTIFYING SPERM TO BE USED IN ASSIS REPRODUCTIVE TECHNOLOGIES
#104Methods, Compositions, and Systems for Modulation of Coronavirus Infection
#105METHODS, SYSTEMS, AND COMPUTER READABLE MEDIA FOR MODULATING TEMPERATURE AND PRODUCING ANALYTE IMAGING DATA
#106COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF AGE-RELATED MACULAR DEGENERATION
#107MULTIFUNCTIONAL MAGNETO-POLYMERIC NANOSYSTEMS FOR RAPID TARGETING, ISOLATION, DETECTION AND SIMULTANEOUS IMAGING OF CIRCULATING TUMOR CELLS
#108PEPTIDE MIMOTOPES OF CLAUDIN 18.2 AND USES THEREOF
#109METHODS FOR IDENTIFYING AND TREATING ANTIBODY-MEDIATED ACQUIRED PRIMARY OR RECURRENT IDIOPATHIC NEPHROTIC SYNDROME
#110APTAMER METHOD
#111Methods and Devices For Complexing Target Entities
#112GPCR19-P2XN RECEPTOR COMPLEX AND USE THEREOF
#113USE OF MODULATORS OF CCR5 IN THE TREATMENT OF CANCER AND CANCER METASTASIS
#114METHOD OF USING EXTRACELLULAR VESICLES TO DETECT COMPLEMENT ACTIVATION, AND USES THEREOF TO ASSESS AND/OR MONITOR TREATMENT OF A COMPLEMENT-MEDIATED DISEASE
#115METHODS FOR DETECTING EARLY DAMAGE OF BLOOD-BRAIN BARRIER DURING CEREBRAL ISCHEMIC STROKE AND APPLICATION THEREOF
#116COMPOSITIONS AND METHODS FOR EARLY DETECTION OF OSTEOPOROSIS
#117Human otic progenitor identification and isolation
#118METHODS FOR DETECTING EARLY DAMAGE OF BLOOD-BRAIN BARRIER IN ISCHEMIC STROKE AND APPLICATION THEREOF
#119IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS
#120Methods and Compositions for Diagnosing and Treating Cancer
#121Anti-MUC16 Antibodies, Antibody-Drug Conjugates, and Bispecific Antigen-Binding Molecules that Bind MUC16 and CD3, and Uses Thereof
#122ANTIBODY AGAINST NECTIN-4 AND APPLICATION THEREOF
#123ADAPTIVE NANOPARTICLE PLATFORMS FOR HIGH THROUGHPUT EXPANSION AND DETECTION OF ANTIGEN-SPECIFIC T CELLS
#124MEANS AND METHODS FOR COUNTERACTING MYELOPROLIFERATIVE OR LYMPHOPROLIFERATIVE DISORDERS
#125IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS
#126COMPOSITIONS AND METHODS FOR TREATMENT
#127METHODS FOR TREATING AND DIAGNOSING SYSTEMIC LUPUS ERYTHEMATOSUS
#128BIOSENSING DEVICE FOR DETECTING CANCER
#129USE OF AUTOMATED PLATFORMS FOR PREPARATION OF BIOMARKER AND ROMANOWSKY-TYPE STAINED SAMPLE PRINTED ON A SLIDE
#130DEVICE OR METHOD FOR DETECTION OF LEUKOCYTE IN DISEASE STATE OR FOR DIAGNOSIS OF LEUKOCYTE-RELATED DISEASE
#131DIAGNOSTIC ASSAYS AND KITS FOR DETECTION OF FOLATE RECEPTOR 1
#132Neutrophil Progenitors and Related Methods and Uses
#133Immune Cell Biomarkers of Cardiovascular Disease
#134METHODS FOR TREATING AND DIAGNOSING SYSTEMIC LUPUS ERYTHEMATOSUS
#135Stem Cell Memory T Cells, Methods and Uses for Modulating Inflammatory Responses, and Diagnosing and Treating Adverse Cardiovascular Events and Disease
#136METHOD OF ISOLATING CIRCULATING TUMOR CELLS
#137METHOD FOR MEASURING PLATELET ACTIVATION BASED ON SOLUBLE CLEC-2 AND PLATELET COUNT
#138POLYPEPTIDE FOR THE THERAPY OF GLOMERULAR KIDNEY DISEASE AND ANALYSIS OF THE COURSE AND PROGNOSIS OF DEPENDENT SYN-DROMES
#139METHOD FOR CONTROLLING OBESITY BY REGULATING ACTIVITY OF TREK1
#140MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
#141MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
#142METHODS FOR DETECTING FOOD ALLERGIES
#143Blood biomarkers and diagnostic methods for small vessel diseases
#144CYTOMETRIC ASSAYS
#145HIGH AVIDITY ANTIGEN RECOGNIZING CONSTRUCTS
#146USE OF SYNAPTOTAGMIN-7 IN THE DIAGNOSIS AND TREATMENT OF BIPOLAR DISORDER
#147Modulators of ATP-binding cassette transporters
#148NOVEL LOX-1 ANTIBODY COMPOSITIONS, LOX1 NEUTRALIZATION ASSAY AND METHODS OF TREATMENT USING SAME
#149METHODS AND DEVICES FOR THE PRODUCTION AND DELIVERY OF BENEFICIAL FACTORS FROM STEM CELLS
#150METHODS FOR IDENTIFYING CANCER
#151RENAL CELL POPULATIONS AND USES THEREOF
#152USE OF SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR LEVELS IN THE MANAGEMENT OF PATIENTS WITH CARDIOVASCULAR DISEASE
#153In Vitro Method for the Prognosis of Progression of a Cancer and of the Outcome in a Patient and Means for Performing Said Method
#154METHODS FOR PREDICTING DRUG RESPONSIVENESS IN SAMPLES FROM CANCER SUBJECTS
#155FREEZE-DRIED PLATELET DERIVATIVE COMPOSITIONS FOR TREATING ANTICOAGULANT-INDUCED COAGULOPATHY
#156PREECLAMPSIA BIOMARKERS AND RELATED SYSTEMS AND METHODS
#157SYSTEMS AND METHODS FOR OPTOGENETIC ACTIVATION AND MONITORING
#158COMPOSITIONS AND METHODS FOR ISOLATING, DETECTING, AND ANALYZING FETAL CELLS
#159Circulating tumor cell based biomarker composition for diagnosis and prognosis of metastatic prostate cancer
#160Methods for categorizing and treating subjects having cystic fibrosis (CF) and at risk for severe pulmonary exacerbation
#161MATERIALS AND METHODS FOR EVALUATING AND TREATING NEUROMYELITIS OPTICA (NMO)
#162Bistable polynucleotide devices for the sensing and quantification of molecular events
#163GENETIC AMPLIFIED TUMOR HOMING NANOPARTICLES AND COMPOSITIONS AND METHODS THEREOF
#164COMPOUNDS AND METHODS FOR THE DETECTION OF TRPV-6 CANCERS AND DRUG DELIVERY
#165METHODS OF TREATING CANCER BY TARGETING TUMOR-ASSOCIATED MACROPHAGES
#166INFLAMMASOME-TARGETED RNA INTERFERENCE APPROACH TO TREATING KIDNEY INJURY AND DISEASE
#167FREEZE-DRIED PLATELET DERIVATIVE COMPOSITIONS FOR TREATING ANTIPLATELET INDUCED COAGULOPATHY
#168NLRP3 INFLAMMASOME INHIBITION
#169Senescent cell biomarkers
#170Biomarker Detection Methods and Systems and Kits for Practicing Same
#171Configuring a smart home controller
#172IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS
#173METHODS AND SYSTEMS FOR IDENTIFYING MODULATORS OF PERVASIVE DEVELOPMENTAL DISORDERS
#174BIOMARKERS FOR DIAGNOSIS OF OCULAR DISEASES AND THE METHOD THEREOF
#175Testing Methods for Determination of T2R Phenotype and Applications Thereof
#176IN VITRO METHOD FOR THE DIAGNOSIS OR PROGNOSIS OF NEURODEGENERATIVE DISORDERS
#177Methods for treating brain metastasis
#178KLOTHO BETA
#179DETECTION OF BCL-2 FAMILY HETERODIMER COMPLEXES AND USE THEREOF
#180AMYLOID PRECURSOR PROTEIN AS A DIAGNOSTIC MARKER FOR BILIARY ATRESIA
#181X-aptamers for the use in detection of SNAP25
#182Anti-idiotypic antibodies against anti-GPRC5D antibodies
#183BIOMARKERS FOR TYPE 1 DIABETES
#184SELECTIVE GLUCOCORTICOID RECEPTOR MODIFIERS FOR TREATING IMPAIRED SKIN WOUND HEALING
#185Method for screening of unpleasant odor masking agents
#186CELL BASED ASSAYS AND KITS FOR ASSESSING SERUM CHOLINERGIC RECEPTOR ACTIVITY
#187RGMa Fragment Based Diagnostic Assay
#188Analyte quantitation
#189METHODS FOR ISOLATING SURFACE MARKER DISPLAYING AGENTS
#190ASSESSING RESPONSIVENESS OF RHEUMATOID ARTHRITIS PATIENTS TO BIOLOGICAL TREATMENT
#191USE OF SOLUBLE TREM-1 LEVELS FOR IDENTIFYING SUBJECTS SUSCEPTIBLE TO RESPOND TO AN ANTI-INFLAMMATORY THERAPY
#192METHODS FOR CAPTURING, ISOLATION, AND TARGETING OF CIRCULATING TUMOR CELLS AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS THEREOF
#193Compound that specifically binds to KIR3DL2 for use in the treatment of peripheral T cell lymphoma
#194COMBINATORIAL USE OF MARKERS TO ISOLATE SYNAPTIC GLIA TO GENERATE SYNAPSES IN A DISH FOR HIGH-THROUGHPUT AND HIGH-CONTENT DRUG DISCOVERY AND TESTING
#195Immuno-based botulinum toxin serotype A activity assays
#196DYSREGULATION OF COVID-19 RECEPTOR ASSOCIATED WITH IBD
#197METHODS FOR MONITORING POLYMORPHONUCLEAR MYELOID DERIVED SUPPRESSOR CELLS
#198Compositions for and Methods of Neutralizing Lipopolysaccharide Toxicity and Methods of Identifying the Same
#199Anti-CXC chemokine receptor antibodies and C-X-C chemokines for the diagnosis of autoimmune disease and graft-versus-host disease
#200Antibodies to MUC16 and methods of use thereof
#201Preeclampsia biomarkers and related systems and methods
#202KLOTHO BETA
#203Epitope specific antibodies that bind cell surface GRP78 and their use for cancer detection
#204Methods and materials for identifying and treating membranous nephropathy
#205Astrotactin1-based compositions and pharmaceutical formulations
#206KIT AND METHOD FOR DETERMINING PROSTATE CANCER MALIGNANCY
#207Method for evaluating quality of human mesenchymal stem cell, and monoclonal antibody for use in said method
#208Dynamic clamps and methods of use thereof
#209METHOD AND KIT FOR THE DIAGNOSIS OF COLORECTAL CANCER
#210Use of ZC3H12B gene or protein and method for establishing animal model of liver disease
#211Antibodies against HPA-1a
#212Antibodies that bind to AXL proteins
#213Antibodies that bind to AXL proteins
#214Receptor tyrosine kinase-like orphan receptor 1 (ROR1) single chain Fv antibody fragment conjugates and methods of use thereof
#215Immuno-based botulinum toxin serotype A activity assays
#216Methods for Monitoring Polymorphonuclear Myeloid Derived Suppressor Cells and Compositions and Methods of Treatment of Cancer
#217Prostate specific membrane antigen binding fibronectin type iii domains
#218Corneal endothelial cell marker
#219Methods of screening for sortilin binding antagonists
#220BIOMARKERS AND USES THEREOF
#221COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF CANCER
#222METHODS AND SYSTEMS FOR PREDICTING DRUG-RESPONSE
#223METHODS OF TREATING CANCERS WITH GPR132 INHIBITORS
#224THERAPEUTIC AND DIAGNOSTIC TARGET FOR CANCER COMPRISING DLL3 BINDING REAGENTS
#225Anti-STAT3 specific antibody and the pharmaceutical composition comprising thereof
#226Method and platform for detecting immunogenicity of tumor neoantigen
#227NEONATAL HYPOXIC-ISCHEMIC ENCEPHALOPATHY SEVERITY DETERMINING METHOD AND PROGNOSIS PREDICTING METHOD
#228DEFECTIVE CALCIUM SIGNALING AS A TOOL IN AUTISM SPECTRUM DISORDERS
#229Expression cassette and host cell for expressing a Vip3-interacting protein
#230Methods for covalently binding a cell surface protein and a ligand
#231Aptamer method
#232ANTIBODY FOR DETECTING EARLY DAMAGE OF BLOOD-BRAIN BARRIER IN ISCHEMIC STROKE AND APPLICATION THEREOF
#233Anti-claudin 18.2 antibodies
#234Antibody specifically binding to FOLR1 and uses thereof
#235IMPROVING ANTI-PD-1 CANCER THERAPY
#236Methods for manufacturing T cells by direct sorting and compositions thereof
#237Anti-folate receptor 1 antibodies and uses thereof
#238Methods and devices for complexing target entities
#239Reagents and Methods for Breast Cancer Detection
#240METHODS FOR DECONTAMINATING CIRCUITS FOR PRODUCING GLUCOSE POLYMERS AND HYDROLYSATES OF GLUCOSE POLYMERS
#241MATERIALS AND METHODS FOR EVALUATING AND TREATING NEUROMYELITIS OPTICA (NMO)
#242IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS
#243ANTIBODY FOR DETECTING EARLY DAMAGE TO BLOOD-BRAIN BARRIER IN ISCHEMIC STROKE AND USE THEREOF
#244ANTIBODY FOR USE IN DETECTING EARLY-STAGE DAMAGE OF BLOOD BRAIN BARRIER DURING CEREBRAL ISCHEMIC STROKE AND APPLICATION THEREOF
#245Diagnosis and therapy of cancer involving cancer stem cells
#246Lipopeptides for Use in Treating Liver Diseases and Cardiovascular Diseases
#247Ratios of sFlt-1 to P1GF or endoglin to P1GF as biomarkers for preeclampsia related adverse outcomes after birth
#248Methods for the diagnosis and treatment of endometriosis
#249Protein biomarker indicators of neurological injury and/or disease and methods of use thereof
#250PSMA-based molecular-genetic reporter system
#251METHOD OF SCREENING COMPOUNDS FOR TREATING CNS DISORDERS
#252Approach for universal monitoring of minimal residual disease in acute myeloid leukemia
#253Compositions and methods for modulating dysferlin expression
#254Diagnostic Assays and Kits for Detection of Folate Receptor 1
#255Biomarker detection methods and systems and kits for practicing same
#256Treating Renal and Liver Dysfunction with TLR4 Antagonists
#257USE OF SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR LEVELS IN THE MANAGEMENT OF PATIENTS WITH CARDIOVASCULAR DISEASE
#258EXTRACTION OF CIRCULATING TUMOR CELLS
#259Screening method for materials that suppress characteristic body odor of elderly people
#260Anti-MUC16 antibodies, antibody-drug conjugates, and bispecific antigen-binding molecules that bind MUC16 and CD3, and uses thereof
#261HLA G-MODIFIED CELLS AND METHODS
#262Multiplexed diagnostic assay for iron and vitamin A deficiency and methods of use thereof
#263Vitamin E-based amphipathic compound, and use thereof
#264Treatment and diagnosis of parkinson's disease using isolated and enriched populations of biofluid-derived extracellular vesicles
#265Anti-pY1235-MET immunological binding reagent
#266DIAGNOSIS AND TREATMENT OF MOTILITY DISORDERS OF THE GUT AND BLADDER, AND OF FIBROMYALGIA
#267Nanovesicle comprising heterodimeric G-protein coupled receptor, method for preparing nanovesicle, field effect transistor-based taste sensor comprising nanovesicle, and method for manufacturing taste sensor
#268Cystic fibrosis transmembrane conductance regulator gene mutations
#269DIAGNOSTIC MARKERS FOR BOVINE TUBERCULOSIS AND USES THEREOF
#270PREECLAMPSIA BIOMARKERS AND RELATED SYSTEMS AND METHODS
#271Methods for treating, preventing and predicting risk of developing breast cancer
#272DETECTION OF T-CELLS EXPRESSING BTNL8
#273Methods for Categorizing and Treating Subjects at Risk for Pulmonary Exacerbation and Disease Progression
#274TENEURIN C-TERMINAL ASSOCIATED PEPTIDES (TCAP) AND METHODS AND USES THEREOF
#275RGMa Fragment Based Diagnostic Assay
#276Means and methods for counteracting myeloproliferative or lymphoproliferative disorders
#277CONSUMABLE CRYOPRESERVED CELLS TRANSIENTLY OVEREXPRESSING GENE(S) ENCODING DRUG TRANSPORTER PROTEIN(S) AND/OR DRUG METABOLIZING ENZYME(S)
#278CONSUMABLE CRYOPRESERVED CELLS TRANSIENTLY OVEREXPRESSING GENE(S) ENCODING DRUG TRANSPORTER PROTEIN(S) AND/OR DRUG METABOLIZING ENZYME(S)
#279Selection of agents modulating gastrointestinal pain
#280Diagnostic method
#281Inhibition of SEMA3A in the prevention and treatment of ocular hyperpermeability
#282HER3 binding agents and uses thereof
#283COMPOSITIONS AND METHODS FOR PROSTATE CANCER ANALYSIS
#284Biological binding molecule
#285DIAGNOSTIC METHODS FOR NEURAL DISORDERS
#286Screening method for pain suppressor and pharmaceutical composition for prevention or treatment of pain
#287Senescent cell biomarkers
#288METHOD FOR INDUCING DIFFERENTIATION OF PLURIPOTENT STEM CELLS INTO GERM CELLS
#289Configuring a Smart Home Controller
#290METHODS AND COMPOSITIONS FOR SINGLE CHAIN VARIABLE REGION ENOX2 ANTIBODIES FOR CANCER DETECTION AND DIAGNOSIS
#291Methods for cancer detection with quantum dots
#292Antibodies that bind cell surface GRP78
#293METHODS AND KITS FOR IDENTIFYING EFFECTOR TREG CELLS
#294Nucleic acid molecules encoding anti-GPRC5D antibodies
#295METHODS OF TREATING CANCERS USING ANTI-GPRC5D ANTIBODIES
#296Acetylcholine receptor-binding peptide
#297Anti-galectin-7 antibody, kit comprising the same, and uses thereof
#298Modulators of ATP-binding cassette transporters
#299BLOOD BIOMARKERS AND DIAGNOSTIC METHODS FOR SMALL VESSEL DISEASES
#300Renal cell populations and uses thereof